The EBV-Encoded Oncoprotein, LMP1, Recruits and Transforms Fibroblasts via an ERK-MAPK-Dependent Mechanism
Latent membrane protein 1 (LMP1), the major oncoprotein encoded by Epstein–Barr virus (EBV), is expressed at widely variable levels in undifferentiated nasopharyngeal carcinoma (NPC) biopsies, fueling intense debate in the field as to the importance of this oncogenic protein in disease pathogenesis....
Main Authors: | Alexandra M Davis, Abigail Rapley, Christopher W Dawson, Lawrence S Young, Mhairi A Morris |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/8/982 |
Similar Items
-
The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling
by: Mhairi A. Morris, et al.
Published: (2018-05-01) -
A Therapeutic Approach to Nasopharyngeal Carcinomas by DNAzymes Targeting EBV LMP-1 Gene
by: Lun-Quan Sun, et al.
Published: (2010-09-01) -
Sequence variation of latent membrane protein 2A (LMP2A)gene from Epstein-Barr virus epitope cytotoxic T-lymphocyte (CTL)related to human leucocyte antigen-A24 (HLA-A24)in peripheral blood sample and cytobrushof nasopharyngeal cancer patients
by: Maya Esther Wullur Moningka, et al.
Published: (2019-07-01) -
Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children
by: Ai Junhong, et al.
Published: (2012-01-01) -
Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer
by: Sylwia Fołtyn, et al.
Published: (2017-05-01)